The Enteropathogenic E. coli Effector EspB Facilitates Microvillus Effacing and Antiphagocytosis by Inhibiting Myosin Function

Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, 4259 Nagatsuta-cho, Midori-ku, Yokohama 226-8501, Japan.
Cell host & microbe (Impact Factor: 12.33). 01/2008; 2(6):383-92. DOI: 10.1016/j.chom.2007.09.012
Source: PubMed


Enteropathogenic Escherichia coli (EPEC) destroys intestinal microvilli and suppresses phagocytosis by injecting effectors into infected cells through a type III secretion system (TTSS). EspB, a component of the TTSS, is also injected into the cytoplasm of host cells. However, the physiological functions of EspB within the host cell cytoplasm remain unclear. We show that EspB binds to myosins, which are a superfamily of proteins that interact with actin filaments and mediate essential cellular processes, including microvillus formation and phagocytosis. EspB inhibits the interaction of myosins with actin, and an EspB mutant that lacks the myosin-binding region maintained its TTSS function but could not induce microvillus effacing or suppress phagocytosis. Moreover, the myosin-binding region of EspB is essential for Citrobacter rodentium, an EPEC-related murine pathogen, to efficiently infect mice. These results suggest that EspB inhibits myosin functions and thereby facilitates efficient infection by EPEC.

Download full-text


Available from: Hiroshi Handa
  • Source
    • "EHEC colonizes the intestine with the aid of a type III secretion system (T3SS) which enables the bacteria to establish a tight adherence to enterocytes and to modify their cytoskeletal proteins, leading to the characteristic attaching and effacing lesion [8]. EspB is a T3SS protein that plays a central role in mediating the EHEC enterocyte adherence [8] [9] [10] [11] [12]. Moreover, EspB is highly immunogenic in human patients [13] [14] [15] and in infected or vaccinated animals [13] [16]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Enterohemorrhagic Escherichia coli (EHEC) have been responsible for several outbreaks of hemolytic-uremic syndrome (HUS) worldwide. HUS is the most common cause of acute renal failure in children and results in fatalities as high as 50% in the elderly. Currently, neither a specific treatment nor a vaccine is available for EHEC. Lactococcus lactis is a generally regarded as safe “GRAS” bacterium that offers a valuable platform for oral vaccine delivery. Toward the development of an oral vaccine against EHEC, we have previously constructed a recombinant L. lactis strain expressing the EHEC antigen, EspB in the cytoplasmic compartment. However, oral immunization of mice with this strain induced weak priming of the immune system. This outcome was attributed to the rather low levels of EspB expressed by this recombinant strain. Therefore, in the present study we optimized the expression of EspB in L. lactis by secreting the antigen either under constitutive or nisin-inducible control. Indeed, oral immunization of mice with the EspB-secreting strains successfully induced specific mucosal and systemic antibody responses. These responses were associated with mixed Th1/Th2 cell responses in Peyer's Patches and mesenteric lymph nodes. Moreover, immunized mice exhibited significant protection against E. coli O157:H7 colonization, as indicated by the reduced amount and/or duration of the bacterial fecal shedding. Our results demonstrate the protective potential of EspB as an oral vaccine against EHEC infection. Additionally, the study demonstrates the efficient delivery of recombinant EspB by the “GRAS” bacterium, L. lactis. The safety profile of L. lactis as a vaccine vehicle can particularly be beneficial to children and elderly as high-risk groups for HUS incidence.
    Full-text · Article · May 2014 · Vaccine
  • Source
    • "Some recent studies have highlighted a significant reduction in GBS EONS with the increased use of prophylactic antibiotics, leading to an increase of rates of non-GBS infection and particularly an increase in EONS caused by Escherichia coli [140]. Enteropathogenic Escherichia coli (EPEC) destroys intestinal microvilli and suppresses phagocytosis to facilitate efficient infection [162]. The bacterial protein Hek, which promotes adherence to and invasion into cultured epithelial cells, has a key role in the transcytosis of Escherichia coli across the intestinal epithelial barrier [163]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The intestinal tract is engaged in a relationship with a dense and complex microbial ecosystem, the microbiota. The establishment of this symbiosis is essential for host physiology, metabolism, and immune homeostasis. Because newborns are essentially sterile, the first exposure to microorganisms and environmental endotoxins during the neonatal period is followed by a crucial sequence of active events leading to immune tolerance and homeostasis. Contact with potent immunostimulatory molecules starts immediately at birth, and the discrimination between commensal bacteria and invading pathogens is essential to avoid an inappropriate immune stimulation and/or host infection. The dysregulation of these tight interactions between host and microbiota can be responsible for important health disorders, including inflammation and sepsis. This review summarizes the molecular events leading to the establishment of postnatal immune tolerance and how pathogens can avoid host immunity and induce neonatal infections and sepsis.
    Full-text · Article · May 2013 · Clinical and Developmental Immunology
  • Source
    • "*Indicates statistical significance (P < 0.05) using oneway ANOVA followed by Tukey's multiple comparison test of TirMC- Ub transfected cells compared to untreated and TirMC transfected host cells. proposed to block EPEC uptake by macrophages via a Tir-independent mechanism (Celli et al., 2000; Iizumi et al., 2007; Dong et al., 2010). It is not understood whether this is the case with infections of nonphagocytes but could constitute another tactic to avoid internalization . "
    [Show abstract] [Hide abstract]
    ABSTRACT: Enteropathogenic Escherichia coli (EPEC) is an extracellular pathogen that alters many host subcellular components during its infectious processes. We have previously shown that EPEC hijacks a large assortment of host cell endocytic components and uses these proteins to form protruding structures called "pedestals" rather than triggering internalization of the bacteria. Other invasive pathogens that also recruit similar endocytic components have been shown to enter their host cells on the ubiquitylation of their host cell receptors. Therefore, we hypothesize that EPEC remains extracellular by maintaining its receptor, translocated intimin receptor (Tir), in an unubiquitylated state. Using immunoprecipitation-Western blots, we demonstrate no association of ubiquitin with Tir. To further elucidate the effect Tir ubiquitylation would have on EPEC during their infections, we engineered Tir-ubiquitin fusion constructs, expressed them in host epithelial cells, and infected them with Δtir EPEC. We found these cells induced a significant increase in EPEC invasion as compared with cells that expressed the Tir construct that lacked ubiquitin conjugation. Our results indicate that the lack of EPEC receptor ubiquitylation is a contributing factor that these microbes use to prevent their internalization into epithelial cells.
    Preview · Article · Aug 2012 · The Anatomical Record Advances in Integrative Anatomy and Evolutionary Biology
Show more